Oncologix Tech Inc (OCLG)

[Mistr Tommy]

Financial Highlights over the past nine months -- Revenues for the three and nine months ending May 31, 2015 were $1,235,656 and $3,625,407, respectively, up from $988,385 and $2,696,776, an increase of 25% and 34%, respectively, from the comparable periods in 2014. -- Gross margins for the three and nine months ending May 31, 2015 were $350,060 and $996,610, respectively, up from $199,628 and $629,976, an improvement of 75% and 58%, respectively, from the comparable periods in 2014. -- General and administrative expenses for the nine months ended May 31, 2015 were $1,379,769, up from $999,910 in fiscal 2014, an increase due to additional general and administrative expenses from the acquisition of Esteemcare. -- During the past nine months, the Company has repaid over $1,470,000 of corporate debt. During the nine months ended May 31, 2015, OCLG raised $1,056,968 through various financing activities, up from $664,818, for the comparable period in 2014.